Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05955508
What this trial is testing

A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma (SMM)
Regeneron Pharmaceuticals 40
Early research (Phase 1)Study completedNCT04322292
What this trial is testing

BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 9
Testing effectiveness (Phase 2)Ended earlyNCT04735575
What this trial is testing

A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Shanghai EpimAb Biotherapeutics Co., Ltd. 40
Very early researchLooking for participantsNCT06775912
What this trial is testing

Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases

Who this might be right for
SLESystemic SclerosisIIM+4 more
Nanjing Bioheng Biotech Co., Ltd. 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05459870
What this trial is testing

CAR-T Cells Targeting Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Shenzhen Geno-Immune Medical Institute 30
Testing effectiveness (Phase 2)Looking for participantsNCT07106684
What this trial is testing

ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Primary Plasma Cell Leukemia

Who this might be right for
Multiple Myeloma, Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, China 20
Early research (Phase 1)UnknownNCT04677452
What this trial is testing

Dose Exploration Study OF JWCAR129, BCMA-Targeted CART for RRMM

Who this might be right for
Safety and Efficacy
The First Affiliated Hospital of Soochow University 24
Early research (Phase 1)Looking for participantsNCT07075185
What this trial is testing

Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMyeloma MultipleMultiple Myeloma Progression+11 more
Kelonia Therapeutics, Inc. 70
Large-scale testing (Phase 3)Active Not RecruitingNCT06413498
What this trial is testing

A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Kite, A Gilead Company 452
Early research (Phase 1)Not Yet RecruitingNCT07490275
What this trial is testing

Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Refractory/Relapsed Systemic Lupus ErythematosusRefractory / Relapsed / Progressive Systemic SclerosisRefractory / Relapsing / Progressive Inflammatory Myopathy+2 more
Institute of Hematology & Blood Diseases Hospital, China
Testing effectiveness (Phase 2)Looking for participantsNCT06900010
What this trial is testing

Evaluate CM336 in Adults With Autoimmune Bullous Disease

Who this might be right for
Autoimmune Bullous Disease
Shandong First Medical University 30
Very early researchLooking for participantsNCT06446128
What this trial is testing

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

Who this might be right for
Non-Hodgkin Lymphoma, B-cell
Shanghai Cell Therapy Group Co.,Ltd 20
Early research (Phase 1)Looking for participantsNCT07224373
What this trial is testing

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
AstraZeneca 24
Early research (Phase 1)Not Yet RecruitingNCT07622862
What this trial is testing

Exploratory Clinical Trial of DQ1001 in Relapsed or Refractory Multiple Myeloma (RRMM)

Who this might be right for
Multiple Myeloma RefractoryMultiple Myeloma Progression
Zhongshan Hospital (Xiamen), Fudan University 16
Early research (Phase 1)UnknownNCT03711864
What this trial is testing

Safety and Efficacy of IM21 Car-t Cells in Patients With Recurrent or Refractory BCMA Positive Multiple Myeloma

Who this might be right for
Multiple Myeloma
Peking Union Medical College Hospital 15
Very early researchLooking for participantsNCT07519187
What this trial is testing

CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms

Who this might be right for
Relapsed or Refractory Plasma Cell Neoplasms
The General Hospital of Western Theater Command 20
Not applicableLooking for participantsNCT07359014
What this trial is testing

Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapse Multiple Myeloma
Second Affiliated Hospital, Zhejiang University, School of Medicine 25
Testing effectiveness (Phase 2)Looking for participantsNCT07477912
What this trial is testing

Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma Refractory
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 30
Testing effectiveness (Phase 2)Looking for participantsNCT05243212
What this trial is testing

Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapse Multiple Myeloma
Sheba Medical Center 75
Very early researchNot Yet RecruitingNCT06359509
What this trial is testing

Study of SYS6020 in BCMA-positive Multiple Myeloma

Who this might be right for
Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Next Page
9